Rapid Influenza Diagnostics Market are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance. According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.

Global rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rising number of geriatric population.

Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rapid-influenza-diagnostics-market

Competitive Analysis: Global Rapid Influenza Diagnostics Market

Few of the major competitors currently working in the global rapid influenza diagnostics market are Abbott, BD, Quidel Corporation., Princeton BioMeditech Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., SA Scientific, Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser Management AG), Luminex Corporation, Boryung Co.,Ltd. among others.

Key Pointers Covered in the Global Rapid Influenza Diagnostics Market Trends and Forecast to 2026

  • Global Rapid Influenza Diagnostics Market New Sales Volumes
  • Global Rapid Influenza Diagnostics Market Replacement Sales Volumes
  • Global Rapid Influenza Diagnostics Market Installed Base
  • Global Rapid Influenza Diagnostics Market By Brands
  • Global Rapid Influenza Diagnostics Market Size
  • Global Rapid Influenza Diagnostics Market Procedure Volumes
  • Global Rapid Influenza Diagnostics Market Product Price Analysis
  • Global Rapid Influenza Diagnostics Market Healthcare Outcomes
  • Global Rapid Influenza Diagnostics Market Cost of Care Analysis
  • Global Rapid Influenza Diagnostics Market Regulatory Framework and Changes
  • Global Rapid Influenza Diagnostics Market Prices and Reimbursement Analysis
  • Global Rapid Influenza Diagnostics Market Shares in Different Regions
  • Recent Developments for Global Rapid Influenza Diagnostics Market Competitors
  • Global Rapid Influenza Diagnostics Market Upcoming Applications
  • Global Rapid Influenza Diagnostics Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-rapid-influenza-diagnostics-market

Key Developments in the Market:

  • In February 2019, Abbott launched BinaxNOW Influenza A & B Card 2, a rapid influenza diagnostic test (RIDT). This reformulated test already received waived status from Clinical Laboratory Improvements Amendments (CLIA) by the U.S. Food and Drug Administration (FDA) for use with Abbott's DIGIVAL diagnostic reader which is specifically designed for the rapid detection of influenza virus. With this product launch the company will establish a footprint in the rapid influenza diagnostic market
  • In August 2018, Boryung BioPharm launched rapid diagnostic kit for the flu, and named it “Flu Fast.” This device collects specimens from patients who has influenza symptoms and detects influenza types A and B by using the immunochromatography method. This product launch will help in the expansion of the company’s product portfolio

Scope of the Rapid Influenza Diagnostics Market

  • Global Rapid Influenza Diagnostics Market By Type of Disease (Influenza A and B), Test Type (STANDARD F Influenza A/B Fluorescence Immunoassay (STANDARD F), Sofia Influenza A + B Fluorescence Immunoassay (Sofia), Immunochromatographic Assay, Real-Time Polymerase Chain Reaction (RT-PCR), Others), End User (Hospitals & Clinics, Laboratories, and Other), Distribution Channel (Direct, Retail), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026
  • Global rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rising number of geriatric population.
  • Rapid influenza diagnostic tests (RIDTs) are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance. According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-rapid-influenza-diagnostics-market

Key insights in the report:

  • Complete and distinct analysis of the market drivers and restraints
  • Key Market players involved in this industry
  • Detailed analysis of the Market Segmentation
  • Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Report Here:

Medical Foods for Inborn Errors of Metabolism Market

Medical Membranes Market